Anemia

Anemia is the condition of having a lower-than-normal red blood cell count or not enough hemoglobin. Anemia is extremely common and affects nearly 25% of the world’s population. It is considered relatively harmless but can be a serious condition with dire implications.

The FDA approved sutimlimab-jome infusion for the treatment of adults with a rare type of anemia.

According to published results, preoperative anemia was associated with an increased risk for complications, non-home discharge and unplanned readmission in patients who underwent total knee arthroplasty.

Aaron T. Gerds, MD, MS, speaks with Healio about predictive biomarkers of week 24 transfusion independence among patients with myelofibrosis.

The FDA granted priority review to luspatercept-aamt for treatment of anemia among adults with non-transfusion-dependent beta-thalassemia.

Approximately one-third of patients with tuberculosis-destroyed lung experienced postoperative complications, with certain subgroups at higher risk, according to new data published in BMC Pulmonary Medicine.

I was disappointed that the recent decision by the Cardiovascular and Renal Drugs Advisory Committee of the FDA will further delay the availability of an orally administered agent for anemia treatment in patients with chronic kidney disease.

The FDA issued a complete response letter to FibroGen indicating it cannot approve the company’s new drug application that seeks approval of roxadustat for anemia of chronic kidney disease.

New research revealed that an algorithm for anemia detection using smartphone photos performed with 72.6% accuracy. It was the top story in hematology/oncology last week.

Anemia is a global public health problem that carries significant risk for mortality and morbidity, particularly among older adults, children and individuals with chronic conditions.